JYEST cell therapy (Institute Of Hematology & Blood Diseases Hospital)

N/A

Report date: 2026/03/19 20:00:18

Base Information

Drug NameJYEST cell therapy (Institute Of Hematology & Blood Diseases Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsEpstein-Barr Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Hematology & Blood Diseases Hospital
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Hematology & Blood Diseases Hospital
Inactive CompaniesN/A
Active IndicationsEpstein-Barr Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A